Showing 1 - 5 results of 5 for search 'Raja Atreya', query time: 0.05s Refine Results
  1. 1
    A Severe Case of Tuberculosis Radiologically and Endoscopically Mimicking Colorectal Cancer with Peritoneal Carcinomatosis

    A Severe Case of Tuberculosis Radiologically and Endoscopically Mimicking Colorectal Cancer with Peritoneal Carcinomatosis by Timo Rath, Raja Atreya, Walter Geißdörfer, Roland Lang, Andreas Nägel, Markus F. Neurath

    Published 2017-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Safety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fast-track dose-escalation clinical trial

    Safety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fa... by Carola Berking, Raja Atreya, Markus F Neurath, Sebastian Zundler, Britta Siegmund, Gerold Schuler, Francesco Vitali, Caroline J Voskens, Diane Stoica, Susanne Roessner, Marita Rosenberg, Manuel Wiesinger, Jutta Wunder, Beatrice Schuler-Thurner

    Published 2021-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study

    Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort s... by Sarah Fischer, Moritz Donhauser, Sarah Cohnen, Konstantin Fietkau, Marcel Vetter, Maria Grübel-Liehr, Peter Dietrich, Timo Rath, Angelika Wilfer, Ludmilla Sologub, Sabine Krebs, Frank Dörje, Daniel Nagore, Sebastian Meyer, Markus F. Neurath, Raja Atreya

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    IL-36 signaling as a drug target in Crohn’s disease patients with IL36RN mutations

    IL-36 signaling as a drug target in Crohn’s disease patients with IL36RN mutations by Julia Hecker, Christina Plattner, Camila A Cancino, Britt-Sabina Löscher, Judith Saurenbach, Marilena Letizia, Dietmar Rieder, TRR241 IBDome Consortium, Inka Freise, Kristina Koop, Clemens Neufert, Désirée Kunkel, Zainab Al Khatim, Lars-Arne Schaafs, Anja Schütz, Christoph Becker, Raja Atreya, Zlatko Trajanoski, Andre Franke, Elena Sonnenberg, Ahmed N Hegazy, Britta Siegmund, Carl Weidinger

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Paucity of viral infection symptoms in patients with immune-mediated inflammatory diseases

    Paucity of viral infection symptoms in patients with immune-mediated inflammatory diseases by Carola Berking, Georg Schett, Andreas Ramming, Raja Atreya, Markus F Neurath, Bernhard Manger, Filippo Fagni, Arnd Kleyer, Milena L Pachowsky, Axel J Hueber, Stefan Kleinert, Karin Manger, Florian Schuch, Monika Ronneberger, David Simon, Michael Sticherling, Koray Tascilar, Christine Meder, Moritz Leppkes, Peter Dietrich, Verena Schoenau, Daniela Bohr, Fabian Hartmann, Selahattin Alp Temiz, Ioanna Minopoulou, Louis Schuster, Melek Yalcin Mutlu, Gerhard Kroenke, Till Orlemann, Johanna Mößner

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: